Evolva Holding S.A. (ELVAY) Research

Evolva Holding SA is a Swiss-headquartered firm, established in 2004, that operates internationally, including in the United States. The company focuses on identifying, scientifically exploring, advancing, and bringing to market natural, bio-based ingredients. These innovative compounds are utilized across a range of sectors, such as the creation of flavors and fragrances, health and wellness products, and protective health solutions. Evolva's diverse product portfolio includes: Veri-te Resveratrol: A plant-derived polyphenol naturally present in grapes, peanuts, cranberries, and other berries. L-Arabinose: A flavoring agent essential for the Maillard reaction. Valencene: An aromatic component found in citrus fruits and derived from citrus. Nootkatone: A grapefruit aroma ingredient produced through the biochemical oxidation of valencene. Vanillin: The principal aromatic constituent extracted from vanilla beans.

Market snapshot

Symbol
ELVAY
Price
$1.16
Day change
0.00%
Market cap
$12.9M
P/E ratio
-19.72x
52-week range
0.8983-1.71
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Alseres Pharmaceuticals, Inc. (ALSE)
  • Claritas Pharmaceuticals, Inc. (CLAZF)
  • TuHURA Biosciences, Inc. (HURA)
  • Laxai Pharma, Ltd. (LAXAF)
  • Lotus Ventures Inc. (LTTSF)
  • Medical Services International Inc. (MSITF)
  • Rite Aid Corporation (RADCQ)

Open Evolva Holding S.A. (ELVAY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.